Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Pregnancy
Interventions: Yoga intervention; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Gum Bleed
Interventions: Sulcular Bristle Tip Technique (SBTT); Other
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Convergence Insufficiency
Interventions: Anodal-Transcranial Direct Current Stimulation, Office-Based Vergence/Accommodative Therapy, Sham Transcranial Direct Current Stimulation; Device · Behavioral
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Oral Leukoplakia
Interventions: Pioglitazone hydrochloride, placebo, laboratory biomarker analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 11
States / cities: Birmingham, Alabama • Iowa City, Iowa • Boston, Massachusetts + 6 more

Conditions: Vitrectomy
Interventions: Ocriplasmin, Placebo; Drug
Lead sponsor: ThromboGenics; Industry
Eligibility: Up to 16 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Muscle Tension Dysphonia
Interventions: Breathing training without a device, Breathing training with a device; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: IUD Insertion
Interventions: Vaginal 2% Lidocaine, Surgical Lubricant Jelly; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Perinatal Depression, Perinatal Anxiety, Parenting Stress
Interventions: Peer mentor texting, Control; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Raynaud's Disease
Interventions: onabotulinum toxin type-A; Drug
Lead sponsor: Southern Illinois University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Postoperative Pain, Opioid Use
Interventions: Decreased opiate prescription, Routine opiate prescription; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease
Interventions: Maharishi Amrit Kalash, vitamin C + E, Inert Placebo Capsule; Dietary Supplement · Other
Lead sponsor: Maharishi International University; Other
Eligibility: 55 Years to 90 Years
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2014
U.S. locations: 1
States / cities: Fairfield, Iowa

Conditions: Cancer
Interventions: Iowa Cancer Affiliate Network (ICAN); Other
Lead sponsor: Mary Charlton; Other
Eligibility: 18 Years to 100 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Fibromyalgia (FM)
Interventions: Low-intensity ultrasound brain stimulation, Sham (No Treatment); Device
Lead sponsor: University of Utah; Other
Eligibility: 22 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Schizophrenia; Psychosis
Interventions: Group Therapy, Treatment as Usual (TAU); Behavioral · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Depressive Episodes, Bipolar I Depression
Interventions: SEP-4199 CR; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 25
States / cities: Huntsville, Alabama • Anaheim, California • Imperial, California + 22 more

Conditions: Retinitis Pigmentosa
Interventions: Valproic Acid, Placebo; Drug
Lead sponsor: Foundation Fighting Blindness; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 6
States / cities: Miami, Florida • Ann Arbor, Michigan • Portland, Oregon + 3 more

Conditions: Liver Diseases
Interventions: Transitional Liver Clinic (TLC); Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 4
States / cities: Chicago, Illinois • Indianapolis, Indiana • Ann Arbor, Michigan + 1 more

Conditions: Post Surgical Pain
Interventions: Bupivacaine 0.25%, Dexamethasone, normal saline; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ALS, Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease, Motor Neuron Disease
Interventions: Tocilizumab, Placebo; Drug · Other
Lead sponsor: Barrow Neurological Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 5
States / cities: Phoenix, Arizona • Kansas City, Kansas • Boston, Massachusetts + 2 more

Conditions: COPD
Interventions: myAirvo3, Pulse oximeter; Device
Lead sponsor: Temple University; Other
Eligibility: 30 Years and older
Enrollment: 642 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 25
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Jacksonville, Florida + 20 more

Conditions: Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma, NSCLC, NSCLC Stage IV
Interventions: L-SABR, Anti-PD-(L)1 based immunotherapy, Platinum based chemotherapy; Radiation · Biological · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 9
States / cities: Miami, Florida • Basking Ridge, New Jersey • Middletown, New Jersey + 6 more

Conditions: Postoperative Pain
Interventions: Pregabalin, Acetaminophen, Placebo 1, Placebo 2; Drug · Other
Lead sponsor: Nevakar, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 2
States / cities: Pasadena, California • Bellaire, Texas

Conditions: Type 2 Diabetes
Interventions: Linagliptin, Basal Bolus, Linagliptin + 50% Glargine dose on discharge, Linagliptin + 80% Glargine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Denver, Colorado • Atlanta, Georgia • Chicago, Illinois + 1 more

Conditions: Hypertension, Blood Pressure, Lifestyle Risk Reduction
Interventions: Home Blood Pressure Monitoring, Telephone Health Coaching; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 39 Years
Enrollment: 316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Search by objective public record fields.

Acute Fetal Response to Prenatal Yoga

Sulcular Bristle Tip Technique (SBTT) With an Electric Toothbrush

Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency

Pioglitazone for Oral Premalignant Lesions

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy

The Effects of Respiratory Training on Voice

Self-Administered Lidocaine Gel for Pain Management With IUD Insertion

Peer Mentor Texting

A Two-Part Study of BOTOX® Therapy for Ischemic Digits

A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery

Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects

Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients

Personalized Ultrasonic Brain Stimulation for Fibromyalgia

Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders

A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

Trial of Oral Valproic Acid for Retinitis Pigmentosa

A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease

Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%

A Trial of Tocilizumab in ALS Subjects

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

A Phase 2 Study to Evaluate Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy

Linagliptin Inpatient Trial

Young Adult Hypertension Self-Management Clinical Trial